II
VYGR icon

Inspire Investing’s Voyager Therapeutics VYGR Stock Holding History

Inspire Investing’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-95,002
Closed -$802K – 873
2023
Q4 		$802K Buy
95,002
+12,346
+15% +$89.6K 0.09% 240
2023
Q3 		$641K Buy
+82,656
New +$755K 0.08% 247

Other funds holding VYGR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Inspire Investing's VYGR Position: Q1 2024 in Review

Inspire Investing sold out of Voyager Therapeutics (VYGR) in Q1 2024, closing a stake of 95,002 shares — an estimated $802K sold.

Inspire Investing first reported a position in VYGR in Q3 2023 and held it in 2 quarters. The position peaked at $802K in Q4 2023. 132 funds tracked by Wall St. Rank hold VYGR as of Q1 2024.

  • Inspire Investing reported no remaining Voyager Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Inspire Investing sold 95,002 Voyager Therapeutics shares in Q1 2024, an estimated $802K.
  • Inspire Investing first reported a position in Voyager Therapeutics in Q3 2023 and held it in 2 quarters.
  • Inspire Investing's Voyager Therapeutics position peaked at $802K in Q4 2023.
  • 132 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2024.

Based on Inspire Investing's 13F filing for Q1 2024, filed 7 May 2024.